Search for: "AstraZeneca Inc." Results 41 - 60 of 340
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jul 2017, 1:11 am by Mark Summerfield
  One further step in that direction was taken by the Canadian Supreme Court on 30 June 2017, when it banished the so-called ‘Promise Doctrine’ of inutility from Canadian patent law: AstraZeneca Canada Inc v Apotex Inc 2017 SCC 36. [read post]
6 Jul 2017, 9:30 pm by Sarah Madigan
AstraZeneca Plc, the appellant in the case, reportedly argued that the doctrine made it too easy for drug companies to lose patents. [read post]
6 Jul 2017, 8:21 am by Steve Brachmann
The Supreme Court of Canada issued a ruling in AstraZeneca Canada Inc. v. [read post]
5 Jul 2017, 11:34 am
 Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium disputeThe AmeriKat Annsley provides a timely and in-depth analysis on the much-awaited decision rendered by the Supreme Court of Canada in the appeal between AstraZeneca Canada v Apotex (2017 SCC 36). [read post]
21 Apr 2017, 6:21 am by Laurence Hooper
AstraZeneca Biopharmaceuticals Inc., but also in an emphatic letter from the U.S. government, which earlier had declined to intervene in the case. [read post]
6 Mar 2017, 10:01 am by David Jensen
“Our chief scientific officer is a former MedImmune/AstraZeneca plc (ADR) (NYSE: AZN) director. [read post]
28 Feb 2017, 7:39 am by Dennis Crouch
Apotex, Inc. where the Federal Circuit affirmed that method claims for “once-daily dosing would likely survive an anticipation challenge by a prior advertisement that disclosed twice-daily dosing. [read post]
16 Aug 2016, 1:38 pm by Ed. Microjuris.com Puerto Rico
She was a financial accountant for IPR Pharmaceuticals, Inc. at Astrazeneca P.L.C. where she was in charge of the preparation and filing of corporate tax forms, analysis of monthly income tax computation, set up pricing commerce reports, preparation of account’s reconciliations, journal cash postings and accounts receivable statements. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
8 Jul 2016, 4:00 am by Alan Macek
Astrazeneca Canada Inc., 2012 FC 559 by Justice Hughes and of accounting experts for a copyright counterclaim by Justice de Montigny in Distrimedic Inc. v. [read post]
15 Apr 2016, 8:26 am by Tom Lamb
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole magnesium) |… [read post]